ESTER QUINTANA CAMPS

Neurodegeneració i Neuroinflamació
Personal de suport a la recerca
Firma
ESTER QUINTANA-CAMPS
Posició
Investigador/a postdoctoral

Projectes

Codi oficial: RD16/0015/0006 Data inici: 01/01/2017 Data fi: 31/12/2021 Investigador/a principal: LLUÍS RAMIÓ I TORRENTÀ Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 5,500 €
Codi oficial: EME-REEM 2020 Data inici: 01/07/2020 Data fi: 30/06/2022 Investigador/a principal: LLUÍS RAMIÓ I TORRENTÀ Organisme finançador: ASOC. ESCLEROSIS MULTIPLE ESPAÑA Ajuda: 40,000 €

Publicacions

Tomas-Roig J, Agbemenyah HY, Celarain N, Quintana E, Ramió-Torrentà L, Havemann-Reinecke U

Dose-dependent effect of cannabinoid WIN-55,212-2 on myelin repair following a demyelinating insult.

SCIENTIFIC REPORTS, 2020, 10, 590-590 dx.doi.org/10.1038/s41598-019-57290-1

Gil-Varea E, Spataro N, Villar LM, Tejeda-Velarde A, Midaglia L, Matesanz F, Malhotra S, Eixarch H, Patsopoulos N, Fernández Ó, Oliver-Martos B, Saiz A, Llufriu S, Ramió-Torrentà L, Quintana E, Izquierdo G, Alcina A, Bosch E, Navarro A, Montalban X, Comabella M

Targeted resequencing reveals rare variants enrichment in multiple sclerosis susceptibility genes.

HUM MUTAT, 2020, 41, 1308-1320 dx.doi.org/10.1002/humu.24016

Toboso I, Tejeda-Velarde A, Alvarez-Lafuente R, Arroyo R, Hegen H, Deisenhammer F, Sainz de la Maza S, Alvarez-Cermeño JC, Izquierdo G, Paramo D, Oliva P, Casanova B, Agüera-Morales E, Franciotta D, Gastaldi M, Fernández O, Urbaneja P, Garcia-Dominguez JM, Romero F, Laroni A, Uccelli A, Perez-Sempere A, Saiz A, Blanco Y, Galimberti D, Scarpini E, Espejo C, Montalban X, Rasche L, Paul F, González I, Álvarez E, Ramo C, Caminero AB, Aladro Y, Calles C, Eguía P, Belenguer-Benavides A, Ramió-Torrentà L, Quintana E, Martínez-Rodríguez JE, Oterino A, López de Silanes C, Casanova LI, Landete L, Frederiksen J, Bsteh G, Mulero P, Comabella M, Hernández MA, Espiño M, Prieto JM, Pérez D, Otano M, Padilla F, García-Merino JA, Navarro L, Muriel A, Frossard LC, Villar LM

New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab.

Frontiers in Neurology, 2020, 11, 579438-579438 dx.doi.org/10.3389/fneur.2020.579438

Muñoz-San Martín M, Reverter G, Robles-Cedeño R, Buxò M, Ortega FJ, Gómez I, Tomàs-Roig J, Celarain N, Villar LM, Perkal H, Fernández-Real JM, Quintana E, Ramió-Torrentà L

Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions.

J NEUROINFLAMM, 2019, 16, 220-220 dx.doi.org/10.1186/s12974-019-1590-5

Quintana E, Coll C, Salavedra-Pont J, Muñoz-San Martín M, Robles-Cedeño R, Tomàs-Roig J, Buxó M, Matute-Blanch C, Villar LM, Montalban X, Comabella M, Perkal H, Gich J, Ramió-Torrentà L

Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain.

EUR J NEUROL, 2018, 25, 1189-1191 dx.doi.org/10.1111/ene.13687

Tomas-Roig J, Piscitelli F, Gil V, Quintana E, Ramió-Torrentà LL, Del Río JA, Moore TP, Agbemenyah H, Salinas G, Pommerenke C, Lorenzen S, Beißbarth T, Hoyer-Fender S, Di Marzo V, Havemann-Reinecke U

Effects of repeated long-term psychosocial stress and acute cannabinoid exposure on mouse corticostriatal circuitries: Implications for neuropsychiatric disorders.

CNS NEUROSCI THER, 2018, 24, 528-538 dx.doi.org/10.1111/cns.12810

Gil-Varea E, Urcelay E, Vilariño-Güell C, Costa C, Midaglia L, Matesanz F, Rodríguez-Antigüedad A, Oksenberg J, Espino-Paisan L, Dessa Sadovnick A, Saiz A, Villar LM, García-Merino JA, Ramió-Torrentà L, Triviño JC, Quintana E, Robles R, Sánchez-López A, Arroyo R, Alvarez-Cermeño JC, Vidal-Jordana A, Malhotra S, Fissolo N, Montalban X, Comabella M

Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course.

J NEUROINFLAMM, 2018, 15, 265-265 dx.doi.org/10.1186/s12974-018-1307-1

Matute-Blanch C, Villar LM, Álvarez-Cermeño JC, Rejdak K, Evdoshenko E, Makshakov G, Nazarov V, Lapin S, Midaglia L, Vidal-Jordana A, Drulovic J, García-Merino A, Sánchez-López AJ, Havrdova E, Saiz A, Llufriu S, Alvarez-Lafuente R, Schroeder I, Zettl UK, Galimberti D, Ramió-Torrentà L, Robles R, Quintana E, Hegen H, Deisenhammer F, Río J, Tintoré M, Sánchez A, Montalban X, Comabella M

Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.

Brain, 2018, 141, 1085-1093 dx.doi.org/10.1093/brain/awy021

Quintana E, Ortega FJ, Robles-Cedeño R, Villar ML, Buxó M, Mercader JM, Alvarez-Cermeño JC, Pueyo N, Perkal H, Fernández-Real JM, Ramió-Torrentà L

miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands.

MULTIPLE SCLEROSIS JOURNAL, 2017, 23, 1716-1726 dx.doi.org/10.1177/1352458516684213

Quintana E, Pineda M, Font A, Vilaseca MA, Tort F, Ribes A, Briones P

Dihydrolipoamide dehydrogenase (DLD) deficiency in a Spanish patient with myopathic presentation due to a new mutation in the interface domain.

J INHERIT METAB DIS, 2010 dx.doi.org/10.1007/s10545-010-9169-4

Formulari de contacte

menu